Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
  • Page of 1
Kharlamov AN. Undiscovered pathology of transient scaffolding t1remains a driver of failures in clinical trials. World J Cardiol. 2018 Oct 26;10(10):165-186. doi: 10.4330/wjc.v10.i10.165. PubMed PMID: 30386494; PubMed Central PMCID: PMC6205848.
Kharlamov AN, Zubarev IV, Shishkina EV, Shur VY. Nanoparticles for treatment of atherosclerosis: challenges of plasmonic photothermal therapy in translational studies. Future Cardiol. 2018 Mar;14(2):109-114. doi: 10.2217/fca-2017-0051. Epub 2018 Jan 16. Review. PubMed PMID: 29336170.
Kharlamov AN, Feinstein JA, Cramer JA, Boothroyd JA, Shishkina EV, Shur V. Plasmonic photothermal therapy of atherosclerosis with nanoparticles: long-term outcomes and safety in NANOM-FIM trial. Future Cardiol. 2017 Jul;13(4):345-363. doi: 10.2217/fca-2017-0009. Epub 2017 Jun 23. PubMed PMID: 28644056.
Kharlamov AN. Cardiovascular burden and percutaneous interventions in Russian Federation: systematic epidemiological update. Cardiovasc Diagn Ther. 2017 Feb;7(1):60-84. doi: 10.21037/cdt.2016.08.10. Review. PubMed PMID: 28164014; PubMed Central PMCID: PMC5253445.
Kharlamov A. Glimpse into the Future of Nanotheranostic Strategies for Regression of Atherosclerosis through the Prism of Systems Biomedicine: Systematic Review of Innovations from Multifunctional Nanoformulations to Devices on Chip. Current Nanomedicine. 2016 December; 6(3):186-218. doi: 10.2174/2468187306666161121142756.
Kharlamov AN. Scaffold thrombosis: Exaggerated illusion, or when statistics rules. Int J Cardiol. 2016 Apr 15;209:206-9. doi: 10.1016/j.ijcard.2016.02.054. Epub 2016 Feb 4. PubMed PMID: 26896624.
Kharlamov AN. Bioresorbable Scaffolds for Atheroregression: Understanding of Transient Scaffolding. Curr Cardiol Rev. 2016;12(1):66-82. doi: 10.2174/1573403x1201160126125853. PubMed PMID: 26818488; PubMed Central PMCID: PMC4807720.
Kharlamov AN. Why do we fail to achieve Glagovian atheroregression in lipid-lowering trials?. Interventional cardiology. 2015 October; 7(5):469-482. doi: 10.2217/ica.15.37.
Kharlamov AN, Tyurnina AE, Veselova VS, Kovtun OP, Shur VY, Gabinsky JL. Silica-gold nanoparticles for atheroprotective management of plaques: results of the NANOM-FIM trial. Nanoscale. 2015 May 7;7(17):8003-15. doi: 10.1039/c5nr01050k. PubMed PMID: 25864858.
Kharlamov AN. Can we adapt histological injury score for optical coherence tomography of coronaries?. Int J Cardiol. 2013 Oct 9;168(4):4322-4. doi: 10.1016/j.ijcard.2013.04.168. Epub 2013 May 20. PubMed PMID: 23701930.
Kharlamov AN. Phenomenon of elongated struts: is optical coherence tomography accurate enough to analyze scaffold area?. Int J Cardiol. 2013 Oct 9;168(4):4280-4. doi: 10.1016/j.ijcard.2013.04.201. Epub 2013 May 20. PubMed PMID: 23701927.
Kharlamov AN. View point: Russian science through the prism of Intelligence: is fraud still possible?. European Heart Journal. 2013 October; doi: 10.13140/RG.2.1.4502.5128.
Muramatsu T, Onuma Y, Zhang YJ, Bourantas CV, Kharlamov A, Diletti R, Farooq V, Gogas BD, Garg S, García-García HM, Ozaki Y, Serruys PW. Progress in treatment by percutaneous coronary intervention: the stent of the future. Rev Esp Cardiol (Engl Ed). 2013 Jun;66(6):483-96. doi: 10.1016/j.rec.2012.12.009. Epub 2013 May 4. Review. PubMed PMID: 24776051.
Lemos PA, Farooq V, Takimura CK, Gutierrez PS, Virmani R, Kolodgie F, Christians U, Kharlamov A, Doshi M, Sojitra P, van Beusekom HM, Serruys PW. Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter. EuroIntervention. 2013 May 20;9(1):148-56. doi: 10.4244/EIJV9I1A21. PubMed PMID: 23685303.
Kharlamov AN, Duckers HJ, van Beusekom HM, Smits PC, Perin EC, Serruys PW. Do we have a future with transcatheter adventitial delivery of stem cells?. Int J Cardiol. 2013 May 10;165(2):217-21. doi: 10.1016/j.ijcard.2012.11.063. Epub 2012 Dec 4. PubMed PMID: 23218580.
Kharlamov AN. Plasmonic photothermal therapy for atheroregression below Glagov threshold. Future Cardiol. 2013 May;9(3):405-25. doi: 10.2217/fca.13.16. Review. PubMed PMID: 23668744.
Onuma Y, Muramatsu T, Kharlamov A, Serruys PW. Freeing the vessel from metallic cage: what can we achieve with bioresorbable vascular scaffolds?. Cardiovasc Interv Ther. 2012 Sep;27(3):141-54. doi: 10.1007/s12928-012-0101-8. Review. PubMed PMID: 22569783.
Kharlamov AN, Gabinsky JL. Plasmonic photothermic and stem cell therapy of atherosclerotic plaque as a novel nanotool for angioplasty and artery remodeling. Rejuvenation Res. 2012 Apr;15(2):222-30. doi: 10.1089/rej.2011.1305. PubMed PMID: 22533437.
Kharlamov AN, Perrish AN, Gabiskiĭ IaL, Ronne Kh, Ivanova EIu. [Vitamin D in the treatment of cardiorenal syndrome in patients with chronic nephropathy]. Kardiologiia. 2012;52(3):33-44. PubMed PMID: 22839442.
Error occurred: The following PMID is not available: 27970246
What would you like to do?
  • Page of 1